Rights and permissions
About this article
Cite this article
Markets for metabolic disorders, botulinum toxins set to soar. Pharmacoecon. Outcomes News 403, 11 (2003). https://doi.org/10.1007/BF03275981
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275981